Header

UZH-Logo

Maintenance Infos

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management


Matucci-Cerinic, Marco; Bruni, Cosimo; Allanore, Yannick; Clementi, Massimo; Dagna, Lorenzo; Damjanov, Nemanja S; de Paulis, Amato; Denton, Christopher P; Distler, Oliver; Fox, David; Furst, Daniel E; Khanna, Dinesh; Krieg, Thomas; Kuwana, Masataka; Lee, Eun Bong; Li, Mengtao; Pillai, Shiv; Wang, Yukai; Zeng, Xiaofeng; Taliani, Gloria (2020). Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management. Annals of the Rheumatic Diseases, 79(6):724-726.

Abstract

Due to the frequent presence of interstitial lung disease and widespread use of immunosuppressive treatment, systemic sclerosis (SSc) patients may be considered at risk for a more severe disease course and higher mortality when they develop Severe Acute Respiratory Syndrome - Coronavirus - 2 (SARS-CoV-2) virus infection. Therefore, with World Scleroderma Foundation endorsement, experts from different specialties including rheumatology, virology and clinical immunology gathered virtually to answer to the main practical clinical questions regarding SARS-CoV-2 infection coming from both patients and physicians. This preliminary advice is aligned with other national and international recommendations, adapted for SSc patients.

Abstract

Due to the frequent presence of interstitial lung disease and widespread use of immunosuppressive treatment, systemic sclerosis (SSc) patients may be considered at risk for a more severe disease course and higher mortality when they develop Severe Acute Respiratory Syndrome - Coronavirus - 2 (SARS-CoV-2) virus infection. Therefore, with World Scleroderma Foundation endorsement, experts from different specialties including rheumatology, virology and clinical immunology gathered virtually to answer to the main practical clinical questions regarding SARS-CoV-2 infection coming from both patients and physicians. This preliminary advice is aligned with other national and international recommendations, adapted for SSc patients.

Statistics

Citations

Dimensions.ai Metrics
5 citations in Web of Science®
6 citations in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Rheumatology Clinic and Institute of Physical Medicine
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Immunology and Allergy
Health Sciences > Rheumatology
Life Sciences > Immunology
Life Sciences > General Biochemistry, Genetics and Molecular Biology
Language:English
Date:June 2020
Deposited On:19 May 2020 14:23
Last Modified:22 May 2020 01:09
Publisher:BMJ Publishing Group
ISSN:0003-4967
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1136/annrheumdis-2020-217407
Related URLs:https://ard.bmj.com/content/early/2020/04/29/annrheumdis-2020-217407.long
PubMed ID:32349982

Download

Full text not available from this repository.
View at publisher

Get full-text in a library